Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000050168 | SCV004297174 | likely pathogenic | Imerslund-Grasbeck syndrome | 2024-03-20 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 5 of the AMN gene. It does not directly change the encoded amino acid sequence of the AMN protein. This variant is present in population databases (rs144077391, gnomAD 0.003%). This variant has been observed in individual(s) with Imerslund-GraÃàsbeck Syndrome (PMID: 22929189). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 56755). Studies have shown that this variant is associated with inconclusive levels of altered splicing (PMID: 22929189). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
Juha Muilu Group; Institute for Molecular Medicine Finland |
RCV000050168 | SCV000082578 | probable-pathogenic | Imerslund-Grasbeck syndrome | no assertion criteria provided | not provided | Converted during submission to Likely pathogenic. |